These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 10658447
21. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation. De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E. Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838 [Abstract] [Full Text] [Related]
22. Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication. Creutzig A, Bullinger M, Cachovan M, Diehm C, Forst HT, Gruss JD, Horsch S, Rogatti W, Scheffler P, Spengel F, Stiegler H. Vasa; 1997 May; 26(2):122-7. PubMed ID: 9174389 [Abstract] [Full Text] [Related]
24. [Circadian variations of cutaneous blood flow in normal subjects and in patients with peripheral arteriopathies. Effect of PGE1 and alpha-cyclodextrin]. Laurora G, Belcaro G. Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):45-9. PubMed ID: 10658444 [Abstract] [Full Text] [Related]
29. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Treat-Jacobson D, Bronas UG, Leon AS. Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669 [Abstract] [Full Text] [Related]
31. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication. Ishihara T, Yamashita Y, Takasaki N, Yamamoto S, Hayashi E, Tahara K, Takenaga M, Yamakawa N, Ishihara T, Kasahara T, Mizushima T. J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586 [Abstract] [Full Text] [Related]
34. Red cell deformability in patients with chronic atheromatous ischemia of the legs. Drozdz W, Panek J, Lejman W. Med Sci Monit; 2001 Aug; 7(5):933-9. PubMed ID: 11535938 [Abstract] [Full Text] [Related]
36. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication. Mohler ER, Klugherz B, Goldman R, Kimmel SE, Wade M, Sehgal CM. Vasc Med; 2000 Aug; 5(4):231-7. PubMed ID: 11213235 [Abstract] [Full Text] [Related]
37. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study. Heer R, Walker S, MacSweeney S. Curr Med Res Opin; 2001 Aug; 17(2):113-5. PubMed ID: 11759179 [Abstract] [Full Text] [Related]
40. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication. Collins P, Ford I, Ball D, Macaulay E, Greaves M, Brittenden J. Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]